Striatal responses to partial dopaminergic lesion: Evidence for compensatory sprouting

Journal of Neuroscience

Volumn 20, Issue 13, 2000, Pages 5102-5114

  Song, David D ^a,c   Haber, Suzanne N ^b  

^a Department of Neurobiology and Anatomy ^*  (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Dopamine; Enkephalin; GAP 43; MPTP; Plasticity; Striatum; Substantia nigra

Indexed keywords

DOPAMINE; NEUROMODULIN; PROENKEPHALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOREACTIVITY; MONKEY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SUBSTANTIA NIGRA;

EID: 0034235742     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-13-05102.2000     Document Type: Article

References (81)

1. Abercrombie ED, Bonatz AE. Zigmond MJ (1990) Effects of L-DOPA on extracellular dopaminc in slriatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525:36-44.
2. Aigner L, Arbcr S, Kapfhammer JP, Laux T, Schneider C, Bottcri F, Brenner H-R, Caroni P (1995) Overexpression of the neural growthassociated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83:269-278.
3. Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P (1993) Chronic administration of l-methyl-4-phenyl-l,2,3,6tetrahydropyridine to monkeys: behavioral, morphological and biochemical correlates. Neuroscience 55:823-832.
4. Anderson PN. Campbell G, Zhang Y. Lieberman AR (1998) Cellular and molecular correlates of the regeneration of adult mammalian CNS axons into peripheral nerve grafts. Prog Brain Res 117:211-232.
5. Andres ME. Gysling K, Bustos G ( 1998) Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway. Brain Res 797:255-266.
6. Apicclla P, Legallet E. Nieoullon A, Trouche E (1995) Quantitative behavioral study of the acute and long-term effects of two-stage bilateral 6-OHDA-induced lesions of the nigrostriatal dopaminergic system in monkeys. Behav Ncurosci 109:329-341.
7. Asselin MC. Soghomonian JJ. Cote PY. Parent A (1994) Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys. NeuroReport 5:2137-2140.
8. Augood SJ. Emson PC. Mitchcll IJ. Boyce S. Clarke CE. Crossman AR (1989) Cellular localisation of enkephalin gene expression in MPTPtreated cynomolgus monkeys. Brain Res Mol Brain Res 6:85-92.
9. Bankicwicz KS. Plunkett RJ. Jacohowitz DM. Kopin IJ, Oldfield EH (1991) Fetal nondopaminergic neural implants in parkinsonian primates. J Neurosurg 74:97-104.
10. Bendotti C, Servadio A. Samanin R (1991) Distribution of GAP-43 mRNA in the brain stem of adult rats as evidenced by in situ hybridization: localization within monoaminergic neurons. J Neurosci 11:600-607.
11. Benes FM, Todtenkopf MS (1999) Effect of age and neuroleptics on tyrosine hydroxylase-IR in sector CA2 of schizophrenic brain. NeuroReport 10:1-4.
12. Benowitz LI, Perrone-Bizzozero NI ( 1991) The relationship of GAP-43 to the development and plasticity of synaptic connections. Ann NY Acad Sci 627:58-74.
13. Benowitz LI, Routtenherg A (1997) GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20:84-91.
14. Bjorklund L, Stromberg I (1997) Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern. Exp Brain Res 113:13-23.
15. Blanchard V, Anglade P. Dziewezapolski G. Savasta M, Agid Y, Raisman-Vozari R (1996) Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res 709:319-325.
16. Boatell ML, Mahy N. Cardozo A, Ambrosio S, Tolosa E, Cruz-Sanchez FF (1992) Neuronal changes in the nigrostriatal pathway of 1-methyl4-phenylpyridine-treated mice. Methods Find Exp Clin Pharmacol 14:781-787.
17. Cass WA, Zahniser NR. Flach KA. Gerhardt GA ( 1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61:2269-2278.
18. Chergui K, Suaud-Chagny MF. Gonon F (1994) Nonlinear relationship between impulse flow, dopaminc release and dopamine elimination in the rat brain in vivo. Neuroscience 62:641-645.
19. Comb M, Seeburg PH, Adelman J, Eiden L. Herbert E (1982) Primary structure of the human Met-and Leu-enkephalin precursor and its mRNA. Nature 295:663-666.
20. Dacko S, Schneider JS (1991) Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms. Neurosci Lett 127:49-52.
21. Dani JW, Armstrong DM. Benowitz LI (1991) Mapping the development of the rat brain by GAP-43 immunocytochemistry. Neuroscience 40:277-287.
22. Davenport RW, Thies E. Cohcn ML (1999) Neuronal growth cone collapse triggers lateral extensions along trailing axons. Nat Neurosci [Erratum (1999) 2:485] 2:254-259.
23. De Olmos JS, Bcltramino CA, and De Olmos De Lorcnzo S (1994) Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants. hypoxia, and physical trauma. Neurotoxicol Terntol 16:545-561.
24. Dunned SB. Rogers DC. Richards SJ (1989) Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts. Exp Brain Res 75:523-535.
25. Elsworth JD. Deutch AY. Redmond Jr DP:. Taylor JR. Sladek Jr JR. Roth RM (1989) Symptomatic and asymptomatic 1-methyl-4-phenyl-l,2.3,6tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience 33:323-331.
26. Fiandaca MS. Kordower JH. Hansen JT. Jiao SS. Gash DM (1988) Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp Neurol 102:76-91.
27. Gerfen CR. McGinty JF. Young WS (1991) Dopamine differentially regulates dynorphin. substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11:1016-1031.
28. Gerlach M, Riederer P ( 1996) Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm (Budapest) 103:987-1041.
29. Gillespie MJ, Stein RB (1983) The relationship between axon diameter, myelin thickness and conduction velocity during atrophy of mammalian peripheral nerves. Brain Res 259:41-56.
30. Gnanalingham KK. Milkowski NA. Smith LA, Hunter AJ. Jenner P. Marsden CD (1995) Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Eur J Pharmacol 277:235-241.
31. Gonon F (1997) Prolonged and extrasynaptic excitatory action of dopamine medialed by D1 receptors in the rat striatum in vivo. J Neurosci 17:5972-5978.
32. Gonon FG, Buda MJ ( 1985) Regulation of dopamine release by impulse How and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14:765-774.
33. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
34. Gudehithlu KP. Duchcmin AM. Tejwani GA. Neff NH. Hadjiconstanlinou M (1991) Preproenkephalin mRNA and methionineenkephalin increase in mouse striatum after l-methyl-4-phenyl-l,2,3,6tetrahydropyridine treatment. J Neurochem 56:1043-1048.
35. Hansen JT. Sakai K, Greenamyre JT. Moran S (1995) Sprouting of dopamincrgic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res 670:197-204.
36. Herrero MT. Augood SJ. Hirsch EC. Javoy-Agid F. Luquin MR. Agid Y. Obeso JA, Emson PC (1995) Effects of L-DOPA on preproenkcphalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68:1189-1198.
37. Hess A (1989) Neuropathological changes in the caudate nucleus elicited by MPTP and their prevention by monoaminc oxidasc inhibition. Brain Res 499:393-396.
38. Hess A, Desiderio C, McAuliffe WG (1990) Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetaminc: immunohistochemical studies. J Neurocytol 19:338-342.
39. Hollerman JR. Grace AA (1990) The effects of dopaminc-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 533:203-212.
40. Jackson-Lewis V, Jakowec M, Burke RE. Przedborski S (1995) Time course and morphology of dopamincrgic neuronal death caused by the neurotoxin l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257-269.
41. Jones GA, Norris SK, Henderson Z (1999) Conduction velocities and membrane properties of different classes of rat septohippocampal neurons recorded in vitro. J Physiol (Lond) 517:867-877.
42. Kita H, Chang HT. Kitai ST (1983) The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis. J Comp Neurol 215:245-257.
43. Kitt CA. Cork LC, Eidelberg F. Joli TH. Price DL (1986) Injury of nigral neurons exposed to l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylasc immunocytochemical study in monkey. Neuroscience 17:1089-1103.
44. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen E-Y, Li JM, Martel L, Levey AE, Mufson EJ, Freeman TB, Olanow CW (1996) Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203-230.
45. Kowalski C, Giraud P (1993) Dopamine decreases striatal enkcphalin turnover and procnkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures. Neuroscicnce 53:665-672.
46. Langston JW. Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of l-methyl-4-phenyl-l,2,5,6tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292:390-394.
47. Langston JW, Forno LS. Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the suhstantia nigra of humans years after l-methyl-4-phenyl-l,2,3,6-tetrahydropyridinc exposure. Ann Neurol 46:598-605.
48. Leviel V, Gobert A, Buibert B (1990) The glutamatc-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neurosciencc 39:305-312.
49. Li SJ, Jing HK, Hudson PM, Owyang V, Nanry K, Tilson HA. Hong JS (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephaline in rat striatum. Mol Brain Res 8:219-225.
50. Lu W, Haber SN (1992) In situ hybridization histochcmistry: A new method for processing material stored for several years. Brain Res 578:155-160.
51. Lynd-Balta E, Haber SN (1994a) The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neurosciencc 59:625-640.
52. Lynd-Balta E. Haber SN (1994h) Primate striatonigral projections: a comparison of the sensorimotor-related striatum and the ventral striatum. J Comp Neurol 343:1-17.
53. Minwegcn P. Friede RL (1984) Conduction velocity varies with osmotically induced changes of the area of the axon's profile. Brain Res 297:105-113.
54. Mocchetti I. Naranjo JR. Costa E (1987) Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. J Pharmacol Exp Ther 241:1120-1124.
55. Morissette M Goulet M, Soghomonian JJ, Blanchet PJ, Calon F, Bedard PJ, Di Paolo T (1997) Preprocnkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. Brain Res Mol Brain Res 49:55-62.
56. Morissette M, Grondin R. Goulet M, Bedard PJ, Di Paolo T (1999) Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine Dl or D2 receptor agonists. J Neurochem 72:682-692.
57. Nisenbaum L, Kitai ST, Gcrfcn CR (1994) Dopaminergic and muscarinic regulation of striatal cnkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. Neuroscience 63:435-449.
58. Normand E, Popovici T, Ontenienle B, Fellmann D, Piatier-Tonneauk D, Auffray C, Block B (1988) Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res 439:39-46.
59. Onn S-P, Berger TW, Stricker EM, Zigmond MJ (1986) Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: Histochemical and neurochemical analysis. Brain Res 376:8-19.
60. Parent A, Lavoie B (1993) The heterogeneity of the mcsostriatal dopaminergic system as revealed in normal and Parkinsonian monkeys. Adv Neurol 60:25-20.
61. Parent A, Assclin MC, Cote PY (1996) Dopaminergic regulation of peptidc gene expression in the striatum of normal and parkinsonian monkeys. Adv Neurol 69:73-77.
62. Robinson TE, Castaneda E, Whishaw IQ (1990) Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetaminc: a review of evidence from microdialysis studies. Can J Psychol 44:253-275.
63. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ (1944) Time course to recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14:2587-2696.
64. Romo R, Cheramy A. Godeheu G. Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus III. Further evidence for the implication of corticostriatal glutamatergic neurons. Neurosciencc 19:1091-1099.
65. Sakai H, Woody CD (1988) Relationships between axonal diameter, soma size, and axonal conduction velocity of HRP-filled, pyramidal tract cells of awake cats. Brain Res 460:1-7.
66. Schneider JS, Yuwiler A, Markham CH (1987) Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res 411:144-150.
67. Sheng JG, McShane LM, Plunkett RJ, Cummins AC, Oldfield EH, Kopin IJ, Palmatier MA (1993) Dopaminergic neuronal sprouting and behavioral recovery in hemi-parkinsonian rats after implantation of amnion cells. Exp Neurol 123:192-203.
68. Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong J-S (1987) Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem 49:1623-1633.
69. Somers DL, Beckstead RM (1990) Striatal preprotachykinin and pre-proenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence. Mol Brain Res 8:143-158.
70. Song DD, Harlan RE (1993) Ontogeny of the proenkephalin system in the rat corpus striatum: its relationship to dopaminergic innervation and transient compartmental expression. Neuroscience 52:883-909.
71. Song DD, Switzer IIIRC, Fudge JL, Haber SN (1999) Striatal consequences of partial dopamine lesion: changes in dopaminergic fiber morphology, degeneration, and preproenkephalin (PPE) expression. Soc Neurosci Abstr 25:1653.
72. Tang F, Costa E, Schwartz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80:3841-3844.
73. Taylor JR, Elsworth JD, Roth RH, Collier TJ, Sladek Jr JR, Redmond DE Jr (1990) Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Prog Brain Res 82:543-559.
74. Tetzlaff W, Zwiers H, Lederis K, Cassar L, Bisby MA (1989) Axonal transport and localization of B-50/GAP-43-like immunoreactivity in regenerating sciatic and facial nerves of the rat. J Neurosci 9:1303-1313.
75. Varastet M, Riche D, Maziere M, Hantraye P (1994) Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease. Neuroscience 63:47-56.
76. Vingerhoets FJ, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB (1994) Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36:765-770.
77. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ (1988) The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887.
78. Willis GL, Donnan GA (1987) Histochcmical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice. Brain Res 402:269-274.
79. Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK ( 1988) Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res 461:335-342.
80. Zigmond MJ, Berger TW, Grace AA, Stricker EM (1989) Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Mol Chem Neuropathol 10:185-200.
81. Zigmond MJ, Ahercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296.